Fouadhassan

ABUS Swing

看多
Fouadhassan 已更新   
NASDAQ:ABUS   Arbutus Biopharma Corporation
$ABUS have a high evaluation above 5.5$ while its currently trading at 3.6 $ expecting profiting from $MRNA and $PFE patent royalties , currently touching rising trend line and it could be a good entry to start accumulating
交易結束:目標達成:
take profit at 4 and 4.5

免責聲明

這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。